Perspective Therapeutics, Inc.
CATX- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000728387
In the last 90 days, Perspective Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 131 institutions reported holding it in 13F filings for Q2 2026, worth $297.6M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Perspective Therapeutics, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 45 | 39 | −6 |
| Shares | 17.5M | 15.9M | −1.55M (−8.8%) |
| Value | $6.78M | $5.79M | −$993.2K (−14.6%) |
New holders (3)
Institutions that held Perspective Therapeutics, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 126,940 | $46.0K | 0.00% |
| Bullseye Investment Management, LLC | 25,000 | $9.00K | 0.01% |
| Douglass Winthrop Advisors, LLC | 10,000 | $4.00K | 0.00% |
Sold out (9)
Institutions that held Perspective Therapeutics, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Highland Private Wealth Management | 972,038 | $377.0K |
| Price T Rowe Associates Inc | 61,500 | $24.0K |
| Charles Schwab Investment Management Inc | 55,471 | $22.0K |
| AdvisorNet Financial, Inc | 44,560 | $17.0K |
| Virtu Financial LLC | 40,836 | $16.0K |
| Advisor Group Holdings, Inc. | 1,500 | $1.00K |
| Horizon Financial Services, LLC | 350 | $136 |
| Bank of America Corp | 206 | $0 |
| Chilton Capital Management LLC | 500 | $0 |